Icecure Medical
Price
Prix
Questions fréquentes
Quelle est la capitalisation boursière de Icecure Medical ?
Quel est le bénéfice par action (BPA) de Icecure Medical ?
Quelles sont les évaluations des analystes et le prix cible de l'action Icecure Medical ?
Quel est le chiffre d'affaires de Icecure Medical sur les douze derniers mois ?
Quel est l'EBITDA de Icecure Medical ?
Quel est le flux de trésorerie disponible de Icecure Medical ?
Quel est le bêta à 5 ans de l'action Icecure Medical ?
Combien d'employés compte Icecure Medical, et à quel secteur d'activité appartient-elle ?
Quel est le flottant des actions de Icecure Medical ?
Finances
Capitalisation boursière
35,27 M $USbêta sur 5 ans
2,53BPA (TTM)
-0,293 $USFree Float
22,69 MRecettes (TTM)
3,34 M $USEBITDA (TTM)
-14,08 M $USCash-flow disponible (TTM)
-11,02 M $USCotation
Notes des analystes
L'objectif de prix est de 3,328 $US et l'action est analysée par 4 analystes.
Acheter
4
Hold
0
Vendre
0
Informations
Icecure Medical Ltd is an Israel-based company that is engaged in the healthcare sector. The Company operates as commercial stage medical device company focusing on the research, development and marketing of cryoablation systems, disposables and technologies based on liquid nitrogen, or LN2, for treating tumors. Cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in breast, lungs, kidneys, bones and other indications. Company's lead product is ProSense system, a single probe system, but in addition the Company developed an additional multi probe system that is expected to have the ability to freeze several tumors simultaneously or larger tumors, named MultiSense system, which has not yet been commercialized.
71
Medical Equipment & Supplies
Soins de santé
Identifiant
ISIN
Ticker primaire